Literature DB >> 11289809

HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway.

S A Swann1, M Williams, C M Story, K R Bobbitt, R Fleis, K L Collins.   

Abstract

HIV causes a chronic infection by evading immune eradication. A key element of HIV immune escape is the HIV-1 Nef protein. Nef causes a reduction in the level of cell surface major histocompatibility complex class I (MHC-I) protein expression, thus protecting HIV-infected cells from anti-HIV cytotoxic T lymphocyte (CTL) recognition and killing. Nef also reduces cell surface levels of the HIV receptor, CD4, by accelerating endocytosis. We show here that endocytosis is not required for Nef-mediated downmodulation of MHC-I molecules. The main effect of Nef is to block transport of MHC-I molecules to the cell surface, leading to accumulation in intracellular organelles. Furthermore, the effect of Nef on MHC-I molecules (but not on CD4) requires phosphoinositide 3-kinase (PI 3-kinase) activity. We propose that Nef diverts MHC-1 proteins into a PI 3-kinase-dependent transport pathway that prevents expression on the cell surface. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289809     DOI: 10.1006/viro.2000.0816

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein.

Authors:  Edda Fiebiger; Craig Story; Hidde L Ploegh; Domenico Tortorella
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.

Authors:  Maya Williams; Jeremiah F Roeth; Matthew R Kasper; Rebekah I Fleis; Chris G Przybycin; Kathleen L Collins
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase.

Authors:  Pamela Stumptner-Cuvelette; Mabel Jouve; Julie Helft; Marc Dugast; Anne-Sophie Glouzman; Karin Jooss; Graça Raposo; Philippe Benaroch
Journal:  Mol Biol Cell       Date:  2003-09-17       Impact factor: 4.138

4.  HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity.

Authors:  Jakob E Larsen; Ramiro H Massol; Thomas J F Nieland; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

5.  Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.

Authors:  Sharilyn Almodovar; Rob Knight; Amanda A Allshouse; Sarah Roemer; Catherine Lozupone; Daniel McDonald; Jeremy Widmann; Norbert F Voelkel; Robert J Shelton; Edu B Suarez; Kenneth W Hammer; Cecile Goujard; Nicola Petrosillo; Gerald Simonneau; Priscilla Y Hsue; Marc Humbert; Sonia C Flores
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-17       Impact factor: 2.205

6.  Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; William G Cumberland; Otto O Yang
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

7.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.

Authors:  Richard D Sloan; Björn D Kuhl; Daniel A Donahue; André Roland; Tamara Bar-Magen; Mark A Wainberg
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

Review 9.  NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections.

Authors:  Raymond M Welsh; Stephen N Waggoner
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 10.  Immune and inflammatory mechanisms in pulmonary arterial hypertension.

Authors:  Hala El Chami; Paul M Hassoun
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.